New Package Leaflets Needed For EU Drugs With Ethanol Excipient
Changes Needed To Explain Potential Effects In Children
New EU guidance has been issued to help sponsors update the package leaflets of medicines that contain ethanol as an excipient to better convey warnings of potential effects in children.
You may also be interested in...
Drug companies in the EU explain how a new pilot scheme on national-level scientific advice service can benefit drug developers.
While the Dutch government negotiates an acceptable price for Leadiant Biosciences’ orphan drug CDCA, a university hospital has resumed supplying pharmacy compounded versions of the drug after addressing initial problems with the sourcing of raw materials.
The European Court of Justice has confirmed the European Medicines Agency’s approach to disclosure of data submitted as part of a marketing authorization application. It is a big disappointment for industry, which nonetheless says it supports responsible data sharing and will support efforts to develop a balanced approach.